<?xml version="1.0" encoding="utf-8"?><html xmlns="http://www.w3.org/1999/xhtml" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:types="http://xbrl.frc.org.uk/general/2019-01-01/types" xmlns:uk-ref="http://xbrl.frc.org.uk/general/2019-01-01/ref" xmlns:common="http://xbrl.frc.org.uk/general/2019-01-01/common" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:curr="http://xbrl.frc.org.uk/cd/2019-01-01/currencies" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:countries="http://xbrl.frc.org.uk/cd/2019-01-01/countries" xmlns:lang="http://xbrl.frc.org.uk/cd/2019-01-01/languages" xmlns:bus="http://xbrl.frc.org.uk/cd/2019-01-01/business" xmlns:accrep="http://xbrl.frc.org.uk/reports/2019-01-01/accrep" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:aurep="http://xbrl.frc.org.uk/reports/2019-01-01/aurep" xmlns:Q1="http://xbrl.org/2005/xbrldt" xmlns:direp="http://xbrl.frc.org.uk/reports/2019-01-01/direp" xmlns:core="http://xbrl.frc.org.uk/fr/2019-01-01/core" xmlns:FRS-102="http://xbrl.frc.org.uk/FRS-102/2019-01-01" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2010-04-20" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:fn="http://www.w3.org/2005/xpath-functions" xmlns:xbrldi="http://xbrl.org/2006/xbrldi"><head><meta content="application/xhtml+xml; charset=UTF-8" http-equiv="Content-Type" /><title>BIO_CHI_LIMITED - Accounts</title><style type="text/css">@page land { size:landscape; }@page port { size:portrait; }.pageFirst { page-break-after:always;  background-color:white;    border-top:1px solid black;  border-bottom:1px solid black;    border-left:1px solid black;    border-right:1px solid black;   } .portraitPage {    page:port;  width:21cm; height:29.7cm; page-break-after:always; background-color:white; border-top:1px solid black; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black; position:relative; } .landscapePage {  page:land;  width:29.7cm; height:21cm; page-break-after:always; background-color:white; border-top:1px solid black; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black; position:relative; } a.tooltip {color:black;text-decoration:none}a.tooltip span{display:none}a.tooltip:hover span{display:inline;position:absolute;z-index:5002;background:#ffffff}a.anchor {color:blue;}a.tooltipRTF {color:black;text-decoration:none;display:none}span:hover a.tooltipRTF {display:block;position:absolute;background:#ffffff}span.tooltipRTFtext {position:absolute;left:10;width:200;border:1pt solid black;text-align:left;font-weight:normal;z-index:5002;bottom:20;font-family:Arial;font-size:9;background-color:#FFFFCC; }.c,.crn,.cjn,.cln,.ccn,.crb,.cjb,.clb,.ccb,.crni,.cjni,.clni,.ccni,.crbi,.cjbi,.clbi,.ccbi{position:absolute;word-wrap:break-word}.crn,.cjn,.cln,.ccn,.crni,.cjni,.clni,.ccni{font-weight:normal}.crb,.clb,.cjb,.ccb,.crbi,.cjbi,.clbi,.ccbi{font-weight:bold}.crni,.cjni,.clni,.ccni,.crbi,.cjbi,.clbi,.ccbi{font-style:italic}.crn,.crb,.crni,.crbi{text-align:right}.cln,.clb,.clni,.clbi{text-align:left}.ccn,.ccb,.ccni,.ccbi{text-align:center}.cjn,.cjb,.cjni,.cjbi{text-align:justify}.fn0{font-size:0px}.fn1{font-size:9.6px;font-family:Arial}.fn2{font-size:11.2px;font-family:Calibri}.fn3{font-size:6.4px;font-family:Calibri}.fn4{font-size:0px;font-family:Arial}.sln{border-top:1px solid black}.dln{border-top:4px double black}.u{text-decoration:underline}ul,li{ margin-top:0px;margin-bottom:0px;margin-right:0px;margin-left:8px;   padding-top:0px;padding-bottom:0px;padding-right:0px;padding-left:8px;} .img_0_0{width:285px;height:30px;position:absolute;background-repeat:no-repeat;background-image:url('data:image/png;base64,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')}</style></head><body xml:lang="en" style="background-color:white"><div class="pageFirst" style="height:727pt;width:516pt;"><div class="ccn fn1 img_0_0" style="top:536.29pt;left:148.38pt;width:214.01pt;"></div><div class="clb fn2" style="top:31.08pt;left:46.61pt;width:423.77pt;"></div><div class="crb fn2" style="top:55.1pt;left:43.61pt;width:420.55pt;"><ix:nonNumeric contextRef="C" name="bus:CountryFormationOrIncorporation"></ix:nonNumeric>Company Registration No. <ix:nonNumeric contextRef="C" name="bus:UKCompaniesHouseRegisteredNumber">10216240</ix:nonNumeric> (England and Wales)</div><div class="ccb fn2" style="top:178.8pt;left:46.61pt;width:420.55pt;"><ix:nonNumeric contextRef="C" name="bus:EntityCurrentLegalOrRegisteredName">BIO CHI LIMITED</ix:nonNumeric></div><div class="ccb fn2" style="top:203.4pt;left:46.61pt;width:420.55pt;">UNAUDITED FINANCIAL STATEMENTS</div><div class="ccb fn2" style="top:228pt;left:46.61pt;width:420.55pt;">FOR THE YEAR ENDED</div><div class="ccb fn2" style="top:252.61pt;left:46.61pt;width:420.55pt;">30 JUNE 2019</div><div class="ccn fn2" style="top:314.46pt;left:46.61pt;width:417.55pt;">PAGES FOR FILING WITH REGISTRAR</div><div class="ccn fn2" style="top:571.32pt;left:46.61pt;width:417.55pt;">Redwood House</div><div class="ccn fn2" style="top:583.7pt;left:46.61pt;width:417.55pt;">65 Bristol Road</div><div class="ccn fn2" style="top:596.09pt;left:46.61pt;width:417.55pt;">Keynsham</div><div class="ccn fn2" style="top:608.48pt;left:46.61pt;width:417.55pt;">Bristol</div><div class="ccn fn2" style="top:620.86pt;left:46.61pt;width:417.55pt;">BS312WB</div></div><div class="portraitPage" style="height:727pt;width:516pt;"><div class="clb fn2" style="top:31.08pt;left:46.61pt;width:423.77pt;"></div><div class="clb fn2" style="top:42.13pt;left:46.61pt;width:423.77pt;"><ix:nonNumeric contextRef="C" name="bus:EntityCurrentLegalOrRegisteredName">BIO CHI LIMITED</ix:nonNumeric></div><div class="clb fn2" style="top:53.2pt;left:46.61pt;width:423.77pt;"></div><div class="clb fn2" style="top:64.26pt;left:46.61pt;width:423.77pt;">CONTENTS</div><div class="cln fn3" style="top:75.33pt;left:46.61pt;width:420.77pt;"></div><div class="clb fn2" style="top:81.65pt;left:46.61pt;width:423.77pt;"></div><div class="cln fn0 sln" style="top:92.71pt;left:46.61pt;width:420.77pt;"></div><div class="cln fn0 sln" style="top:695.49pt;left:46.61pt;width:420.77pt;"></div><div class="clb fn2" style="top:118.71pt;left:409.6pt;width:60.79pt;">Page</div><div class="cln fn2" style="top:143.49pt;left:46.61pt;width:362.98pt;">Company information</div><div class="cln fn2" style="top:143.49pt;left:409.6pt;width:57.79pt;">1</div><div class="cln fn2" style="top:168.26pt;left:46.61pt;width:362.98pt;">Balance sheet</div><div class="cln fn2" style="top:168.26pt;left:409.6pt;width:57.79pt;">2</div><div class="cln fn2" style="top:193.04pt;left:46.61pt;width:362.98pt;">Notes to the financial statements</div><div class="cln fn2" style="top:193.04pt;left:409.6pt;width:57.79pt;">3 - 5</div></div><div class="portraitPage" style="height:727pt;width:516pt;"><div class="clb fn2" style="top:31.08pt;left:46.61pt;width:423.77pt;"></div><div class="clb fn2" style="top:42.13pt;left:46.61pt;width:423.77pt;"><ix:nonNumeric contextRef="C" name="bus:EntityCurrentLegalOrRegisteredName">BIO CHI LIMITED</ix:nonNumeric></div><div class="clb fn2" style="top:53.2pt;left:46.61pt;width:423.77pt;"></div><div class="clb fn2" style="top:64.26pt;left:46.61pt;width:423.77pt;">COMPANY INFORMATION</div><div class="cln fn3" style="top:75.33pt;left:46.61pt;width:420.77pt;"></div><div class="clb fn2" style="top:81.65pt;left:46.61pt;width:423.77pt;"></div><div class="cln fn0 sln" style="top:92.71pt;left:46.61pt;width:420.77pt;"></div><div class="cln fn0 sln" style="top:695.49pt;left:46.61pt;width:420.77pt;"></div><div class="ccn fn1" style="top:701.96pt;left:46.61pt;width:420.77pt;">- 1 -</div><div class="clb fn2" style="top:118.71pt;left:46.61pt;width:115.49pt;">Director</div><div class="cln fn2" style="top:118.71pt;left:159.11pt;width:141.7pt;"><ix:nonNumeric contextRef="C_WC_WD" name="bus:NameEntityOfficer">Mr T West</ix:nonNumeric></div><div class="cln fn2" style="top:118.71pt;left:300.81pt;width:145.43pt;"></div><div class="clb fn2" style="top:143.49pt;left:46.61pt;width:115.49pt;">Company number</div><div class="cln fn2" style="top:143.49pt;left:159.11pt;width:287.13pt;"><ix:nonNumeric contextRef="C" name="bus:UKCompaniesHouseRegisteredNumber">10216240</ix:nonNumeric></div><div class="clb fn2" style="top:168.26pt;left:46.61pt;width:115.49pt;">Registered office</div><div class="cln fn2" style="top:168.26pt;left:159.11pt;width:287.13pt;"><ix:nonNumeric contextRef="C_WF_WG" name="bus:AddressLine1">Units 3-4 Chapel Court Chapel Street</ix:nonNumeric></div><div class="cln fn2" style="top:180.65pt;left:159.11pt;width:287.13pt;"><ix:nonNumeric contextRef="C_WF_WG" name="bus:AddressLine2">St Phillips</ix:nonNumeric></div><div class="cln fn2" style="top:193.04pt;left:159.11pt;width:287.13pt;"><ix:nonNumeric contextRef="C_WF_WG" name="bus:PrincipalLocation-CityOrTown">Bristol</ix:nonNumeric></div><div class="cln fn2" style="top:205.42pt;left:159.11pt;width:287.13pt;"><ix:nonNumeric contextRef="C_WF_WG" name="bus:CountyRegion">United Kingdom</ix:nonNumeric></div><div class="cln fn2" style="top:217.81pt;left:159.11pt;width:287.13pt;"><ix:nonNumeric contextRef="C_WF_WG" name="bus:PostalCodeZip">BS2 0UL</ix:nonNumeric></div><div class="clb fn2" style="top:242.58pt;left:46.61pt;width:115.49pt;">Accountants</div><div class="cln fn2" style="top:242.58pt;left:159.11pt;width:287.13pt;"><ix:nonNumeric contextRef="C" name="bus:NameEntityAuditors">TC Group</ix:nonNumeric></div><div class="cln fn2" style="top:254.98pt;left:159.11pt;width:287.13pt;">Redwood House</div><div class="cln fn2" style="top:267.36pt;left:159.11pt;width:287.13pt;">65 Bristol Road</div><div class="cln fn2" style="top:279.75pt;left:159.11pt;width:287.13pt;">Keynsham</div><div class="cln fn2" style="top:292.14pt;left:159.11pt;width:287.13pt;">Bristol</div><div class="cln fn2" style="top:304.52pt;left:159.11pt;width:287.13pt;">BS312WB</div></div><div class="portraitPage" style="height:727pt;width:516pt;"><div class="clb fn2" style="top:31.08pt;left:46.61pt;width:423.77pt;"></div><div class="clb fn2" style="top:42.13pt;left:46.61pt;width:423.77pt;"><ix:nonNumeric contextRef="C" name="bus:EntityCurrentLegalOrRegisteredName">BIO CHI LIMITED</ix:nonNumeric></div><div class="clb fn2" style="top:53.2pt;left:46.61pt;width:423.77pt;"></div><div class="clb fn2" style="top:64.26pt;left:46.61pt;width:423.77pt;">BALANCE SHEET </div><div class="cln fn3" style="top:75.33pt;left:46.61pt;width:420.77pt;"></div><div class="clbi fn2" style="top:81.65pt;left:46.61pt;width:423.77pt;">AS AT <div style="display:inline">30 JUNE 2019<div style="display:none"><ix:nonNumeric contextRef="B" format="ixt:datelonguk" name="bus:BalanceSheetDate">30 June 2019</ix:nonNumeric></div></div></div><div class="clb fn2" style="top:92.71pt;left:46.61pt;width:423.77pt;"></div><div class="cln fn0 sln" style="top:103.78pt;left:46.61pt;width:420.77pt;"></div><div class="cln fn0 sln" style="top:695.49pt;left:46.61pt;width:420.77pt;"></div><div class="ccn fn1" style="top:701.96pt;left:46.61pt;width:420.77pt;">- 2 -</div><div class="clb fn2" style="top:117.39pt;left:297.71pt;width:59.56pt;">2019</div><div class="clb fn2" style="top:117.39pt;left:410.83pt;width:59.55pt;">2018</div><div class="ccb fn2" style="top:129.78pt;left:206.98pt;width:37.17pt;">Notes</div><div class="crb fn2" style="top:129.78pt;left:238.15pt;width:59.56pt;">£</div><div class="crb fn2" style="top:129.78pt;left:294.71pt;width:59.56pt;">£</div><div class="crb fn2" style="top:129.78pt;left:351.27pt;width:59.55pt;">£</div><div class="crb fn2" style="top:129.78pt;left:407.83pt;width:59.55pt;">£</div><div class="cln fn4" style="top:129.78pt;left:468.03pt;width:0.65pt;"></div><div class="clb fn2" style="top:166.94pt;left:46.61pt;width:197.53pt;">Current assets</div><div class="cln fn2" style="top:179.32pt;left:46.61pt;width:160.36pt;">Cash at bank and in hand</div><div class="crn fn2" style="top:179.32pt;left:241.15pt;width:56.56pt;">-</div><div class="crn fn2" style="top:179.32pt;left:354.27pt;width:56.55pt;"><ix:nonFraction contextRef="E" decimals="0" scale="0" unitRef="GBP" name="core:CashBankOnHand">504</ix:nonFraction></div><div class="clb fn2" style="top:191.71pt;left:46.61pt;width:163.36pt;">Creditors: amounts falling due within one year</div><div class="ccb fn2" style="top:202.77pt;left:206.98pt;width:37.17pt;">2</div><div class="crn fn2" style="top:202.77pt;left:243.89pt;width:56.56pt;">(<ix:nonFraction contextRef="B_WQ_XR" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:Creditors">11,674</ix:nonFraction>)</div><div class="crn fn2" style="top:202.77pt;left:357.02pt;width:56.55pt;">(<ix:nonFraction contextRef="E_WQ_XR" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:Creditors">5,800</ix:nonFraction>)</div><div class="cln fn0 sln" style="top:220.7pt;left:272.47pt;width:25.24pt;"></div><div class="cln fn0 sln" style="top:220.7pt;left:385.59pt;width:25.24pt;"></div><div class="clb fn2" style="top:227.55pt;left:46.61pt;width:254.09pt;">Net current liabilities</div><div class="crn fn2" style="top:227.55pt;left:300.46pt;width:56.56pt;">(<ix:nonFraction contextRef="B" decimals="0" scale="0" unitRef="GBP" sign="-" format="ixt:numcommadot" name="core:NetCurrentAssetsLiabilities">11,674</ix:nonFraction>)</div><div class="crn fn2" style="top:227.55pt;left:413.58pt;width:56.55pt;">(<ix:nonFraction contextRef="E" decimals="0" scale="0" unitRef="GBP" sign="-" format="ixt:numcommadot" name="core:NetCurrentAssetsLiabilities">5,296</ix:nonFraction>)</div><div class="cln fn0 dln" style="top:245.47pt;left:329.03pt;width:25.24pt;"></div><div class="cln fn0 dln" style="top:245.47pt;left:442.15pt;width:25.24pt;"></div><div class="clb fn2" style="top:264.71pt;left:46.61pt;width:163.36pt;">Capital and reserves</div><div class="cln fn2" style="top:277.1pt;left:46.61pt;width:160.36pt;">Profit and loss reserves</div><div class="ccb fn2" style="top:277.1pt;left:206.98pt;width:37.17pt;"></div><div class="crn fn2" style="top:277.1pt;left:300.46pt;width:56.56pt;">(<ix:nonFraction contextRef="B_XT_XU" decimals="0" scale="0" unitRef="GBP" sign="-" format="ixt:numcommadot" name="core:Equity">11,674</ix:nonFraction>)</div><div class="crn fn2" style="top:277.1pt;left:413.58pt;width:56.55pt;">(<ix:nonFraction contextRef="E_XT_XU" decimals="0" scale="0" unitRef="GBP" sign="-" format="ixt:numcommadot" name="core:Equity">5,296</ix:nonFraction>)</div><div class="cln fn0 dln" style="top:295.02pt;left:329.03pt;width:25.24pt;"></div><div class="cln fn0 dln" style="top:295.02pt;left:442.15pt;width:25.24pt;"></div><div class="cln" style="top:314pt;left:47pt;width:421pt;text-align:justify;font-family:Calibri;font-size:8.4pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><ix:nonNumeric contextRef="C" name="direp:EntityHasTakenExemptionUnderCompaniesActInNotPublishingItsOwnProfitLossAccountTruefalse"><span class="fn2"><ix:exclude>The director of the company has elected not to include a copy of the profit and loss account within the financial statements.</ix:exclude><span style="display:none">true</span></span></ix:nonNumeric></p></div><div class="cln" style="top:350pt;left:47pt;width:421pt;text-align:justify;font-family:Calibri;font-size:8.4pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><ix:nonNumeric contextRef="C" name="direp:StatementThatCompanyEntitledToExemptionFromAuditUnderSection477CompaniesAct2006RelatingToSmallCompanies"><span class="fn2">For the financial year ended 30 June 2019 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.</span></ix:nonNumeric></p></div><div class="cln" style="top:386pt;left:47pt;width:421pt;text-align:justify;font-family:Calibri;font-size:8.4pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><ix:nonNumeric contextRef="C" name="direp:StatementThatDirectorsAcknowledgeTheirResponsibilitiesUnderCompaniesAct"><span class="fn2">The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.</span></ix:nonNumeric></p></div><div class="cln" style="top:422pt;left:47pt;width:421pt;text-align:justify;font-family:Calibri;font-size:8.4pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><ix:nonNumeric contextRef="C" name="direp:StatementThatMembersHaveNotRequiredCompanyToObtainAnAudit" continuedAt="C_YI_0"><span class="fn2">T</span></ix:nonNumeric><span class="fn2"></span><ix:continuation id="C_YI_0" continuedAt="C_YI_1"><span class="fn2">he members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476</span></ix:continuation><span class="fn2"></span><ix:continuation id="C_YI_1"><span class="fn2">.</span></ix:continuation></p></div><div class="cln" style="top:457pt;left:47pt;width:421pt;text-align:justify;font-family:Calibri;font-size:8.4pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><ix:nonNumeric contextRef="C" name="direp:StatementThatAccountsHaveBeenPreparedInAccordanceWithProvisionsSmallCompaniesRegime"><span class="fn2">These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.</span></ix:nonNumeric></p></div><div class="cjn fn2" style="top:493.12pt;left:46.61pt;width:420.77pt;">The financial statements were approved and signed by the director and authorised for issue on <ix:nonNumeric contextRef="B" format="ixt:datelonguk" name="core:DateAuthorisationFinancialStatementsForIssue">31 March 2020</ix:nonNumeric></div><div class="cln fn2" style="top:542.67pt;left:46.61pt;width:420.77pt;"><ix:nonNumeric contextRef="C_WC_WD" name="core:DirectorSigningFinancialStatements"></ix:nonNumeric>Mr T West</div><div class="clb fn2" style="top:555.06pt;left:46.61pt;width:423.77pt;">Director</div><div class="clb fn2" style="top:579.83pt;left:46.61pt;width:423.77pt;">Company Registration No. 10216240</div><div class="ccn fn2" style="top:592.22pt;left:46.61pt;width:420.77pt;">The notes on pages 3 to 5 form part of these financial statements</div></div><div class="portraitPage" style="height:727pt;width:516pt;"><div class="clb fn2" style="top:31.08pt;left:46.61pt;width:423.77pt;"></div><div class="clb fn2" style="top:42.13pt;left:46.61pt;width:423.77pt;"><ix:nonNumeric contextRef="C" name="bus:EntityCurrentLegalOrRegisteredName">BIO CHI LIMITED</ix:nonNumeric></div><div class="clb fn2" style="top:53.2pt;left:46.61pt;width:423.77pt;"></div><div class="clb fn2" style="top:64.26pt;left:46.61pt;width:423.77pt;">NOTES TO THE FINANCIAL STATEMENTS </div><div class="cln fn3" style="top:75.33pt;left:46.61pt;width:420.77pt;"></div><div class="clbi fn2" style="top:81.65pt;left:46.61pt;width:423.77pt;">FOR THE YEAR ENDED 30 JUNE 2019</div><div class="clb fn2" style="top:92.71pt;left:46.61pt;width:423.77pt;"></div><div class="cln fn0 sln" style="top:103.78pt;left:46.61pt;width:420.77pt;"></div><div class="cln fn0 sln" style="top:695.49pt;left:46.61pt;width:420.77pt;"></div><div class="ccn fn1" style="top:701.96pt;left:46.61pt;width:420.77pt;">- 3 -</div><div class="clb fn2" style="top:117.39pt;left:46.61pt;width:24.12pt;">1</div><div class="clb fn2" style="top:117.39pt;left:67.73pt;width:402.65pt;">Accounting policies</div><div class="cln fn4" style="top:117.39pt;left:468.03pt;width:0.65pt;"></div><div class="clb fn2" style="top:142.16pt;left:67.73pt;width:402.65pt;">Company information</div><div class="cln" style="top:155pt;left:68pt;width:400pt;text-align:justify;font-family:Calibri;font-size:8.4pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><span class="fn2">Bio Chi Limited</span><span class="fn2"> (10216240)</span><span class="fn2"> is a</span><span class="fn2"> private </span><span class="fn2">company</span><span class="fn2"> limited by shares</span><span class="fn2"> incorporated in England and Wales.</span><span class="fn2"> </span><span class="fn2">The registered office is</span><span class="fn2"> Units 3-4 Chapel Court Chapel Street, St Phillips, Bristol, United Kingdom, BS2 0UL.</span></p></div><div class="clb fn2" style="top:190.39pt;left:46.61pt;width:24.12pt;">1.1</div><div class="clb fn2" style="top:190.39pt;left:67.73pt;width:402.65pt;">Accounting convention</div><div class="cln" style="top:203pt;left:68pt;width:400pt;text-align:justify;font-family:Calibri;font-size:8.4pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><ix:nonNumeric contextRef="C" name="core:StatementComplianceWithApplicableReportingFramework"><span class="fn2">These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.</span></ix:nonNumeric></p></div><div class="cln" style="top:272pt;left:68pt;width:400pt;text-align:justify;font-family:Calibri;font-size:8.4pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><span class="fn2">The financial statements are prepared in</span><span class="fn2"> sterling</span><span class="fn2">, which is the functional currency of the company. </span><span class="fn2">Monetary a</span><span class="fn2">mounts </span><span class="fn2">in these financial statements are </span><span class="fn2">rounded to the nearest £.</span></p></div><div class="cln" style="top:307pt;left:68pt;width:400pt;text-align:justify;font-family:Calibri;font-size:8.4pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><ix:nonNumeric contextRef="C" name="core:GeneralDescriptionBasisMeasurementUsedInPreparingFinancialStatements"><span class="fn2">The financial statements have been prepared under the historical cost convention, modified to include the revaluation of freehold properties and to include investment properties and certain financial instruments at fair value. The principal accounting policies adopted are set out below.</span></ix:nonNumeric></p></div><div class="clb fn2" style="top:378.82pt;left:46.61pt;width:24.12pt;">1.2</div><div class="clb fn2" style="top:378.82pt;left:67.73pt;width:402.65pt;">Turnover</div><div class="cln" style="top:391pt;left:68pt;width:400pt;text-align:justify;font-family:Calibri;font-size:8.4pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><ix:nonNumeric contextRef="C" name="core:RevenueRecognitionPolicy" continuedAt="C_YJ_0"><span class="fn2">Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business</span></ix:nonNumeric><span class="fn2"></span><ix:continuation id="C_YJ_0" continuedAt="C_YJ_1"><span class="fn2">, and</span></ix:continuation><span class="fn2"></span><ix:continuation id="C_YJ_1" continuedAt="C_YJ_2"><span class="fn2"> is shown net of VAT and other sales related taxes</span></ix:continuation><span class="fn2"></span><ix:continuation id="C_YJ_2" continuedAt="C_YJ_3"><span class="fn2">. </span></ix:continuation><span class="fn2"></span><ix:continuation id="C_YJ_3" continuedAt="C_YJ_4"><span class="fn2">The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.</span></ix:continuation></p><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><span class="fn2">&#160;</span></p><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><ix:continuation id="C_YJ_4" continuedAt="C_YJ_5"><span class="fn2">When cash inflows are deferred and represent a financing arrangement, the fair value of the consideration is the present value of the future receipts. The difference between the fair value of the consideration and the nominal amount received is recognised as interest income.</span></ix:continuation></p></div><div class="cln" style="top:482pt;left:68pt;width:400pt;text-align:justify;font-family:Calibri;font-size:8.4pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><ix:continuation id="C_YJ_5" continuedAt="C_YJ_6"><span class="fn2">Revenue from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have passed to the buyer</span></ix:continuation><span class="fn2"></span><ix:continuation id="C_YJ_6" continuedAt="C_YJ_7"><span class="fn2"> (usually on dispatch of the goods)</span></ix:continuation><span class="fn2"></span><ix:continuation id="C_YJ_7" continuedAt="C_YJ_8"><span class="fn2">, the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the entity and the costs incurred or to be incurred in respect of the transaction can be measured reliably.</span></ix:continuation></p></div><div class="cln" style="top:540pt;left:68pt;width:400pt;text-align:justify;font-family:Calibri;font-size:8.4pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><ix:continuation id="C_YJ_8" continuedAt="C_YJ_9"><span class="fn2">Revenue from contracts for the provision of professional services is recognised by reference to the stage of completion when the stage of completion, costs incurred and costs to complete can be estimated reliably. The stage of completion is calculated by comparing costs incurred, mainly in relation to contractual hourly staff rates and materials, as a proportion of total costs.  Where the outcome cannot be estimated reliably, revenue is recognised only to the extent of the expenses recognised that </span></ix:continuation><span class="fn2"></span><ix:continuation id="C_YJ_9" continuedAt="C_YJ_10"><span class="fn2">it is probable will be</span></ix:continuation><span class="fn2"></span><ix:continuation id="C_YJ_10" continuedAt="C_YJ_11"><span class="fn2"> recover</span></ix:continuation><span class="fn2"></span><ix:continuation id="C_YJ_11" continuedAt="C_YJ_12"><span class="fn2">ed</span></ix:continuation><span class="fn2"></span><ix:continuation id="C_YJ_12"><span class="fn2">.</span></ix:continuation></p></div><div class="clb fn2" style="top:608.85pt;left:46.61pt;width:24.12pt;">1.3</div><div class="clb fn2" style="top:608.85pt;left:67.73pt;width:402.65pt;">Cash at bank and in hand</div><div class="cln" style="top:621pt;left:68pt;width:400pt;text-align:justify;font-family:Calibri;font-size:8.4pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><ix:nonNumeric contextRef="C" name="core:CashCashEquivalentsPolicy" continuedAt="C_YK_0"><span class="fn2">Cash at bank and in hand </span></ix:nonNumeric><span class="fn2"></span><ix:continuation id="C_YK_0" continuedAt="C_YK_1"><span class="fn2">are basic financial assets</span></ix:continuation><span class="fn2"></span><ix:continuation id="C_YK_1" continuedAt="C_YK_2"><span class="fn2"> and</span></ix:continuation><span class="fn2"></span><ix:continuation id="C_YK_2"><span class="fn2"> include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.</span></ix:continuation></p></div></div><div class="portraitPage" style="height:727pt;width:516pt;"><div class="clb fn2" style="top:31.08pt;left:46.61pt;width:423.77pt;"></div><div class="clb fn2" style="top:42.13pt;left:46.61pt;width:423.77pt;"><ix:nonNumeric contextRef="C" name="bus:EntityCurrentLegalOrRegisteredName">BIO CHI LIMITED</ix:nonNumeric></div><div class="clb fn2" style="top:53.2pt;left:46.61pt;width:423.77pt;"></div><div class="clb fn2" style="top:64.26pt;left:46.61pt;width:423.77pt;">NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)</div><div class="cln fn3" style="top:75.33pt;left:46.61pt;width:420.77pt;"></div><div class="clbi fn2" style="top:81.65pt;left:46.61pt;width:423.77pt;">FOR THE YEAR ENDED 30 JUNE 2019</div><div class="clb fn2" style="top:92.71pt;left:46.61pt;width:423.77pt;"></div><div class="cln fn0 sln" style="top:103.78pt;left:46.61pt;width:420.77pt;"></div><div class="clb fn2" style="top:116.72pt;left:46.61pt;width:24.12pt;">1</div><div class="clb fn2" style="top:116.72pt;left:67.73pt;width:402.65pt;">Accounting policies</div><div class="crb fn2" style="top:116.72pt;left:378.06pt;width:89.32pt;">(Continued)</div><div class="cln fn0 sln" style="top:695.49pt;left:46.61pt;width:420.77pt;"></div><div class="ccn fn1" style="top:701.96pt;left:46.61pt;width:420.77pt;">- 4 -</div><div class="clb fn2" style="top:140.78pt;left:46.61pt;width:24.12pt;">1.4</div><div class="clb fn2" style="top:140.78pt;left:67.73pt;width:402.65pt;">Financial instruments</div><div class="cln" style="top:153pt;left:68pt;width:400pt;text-align:justify;font-family:Calibri;font-size:8.4pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><ix:nonNumeric contextRef="C" name="core:FinancialInstrumentsClassificationPolicy" continuedAt="C_YL_0"><span class="fn2">The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments. </span></ix:nonNumeric></p><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><span class="fn2">&#160;</span></p><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><ix:continuation id="C_YL_0" continuedAt="C_YL_1"><span class="fn2">Financial instruments are recognised in the company&apos;s balance sheet when the company becomes party to the contractual provisions of the instrument.</span></ix:continuation></p><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><span class="fn2">&#160;</span></p><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><ix:continuation id="C_YL_1" continuedAt="C_YL_2"><span class="fn2">Financial assets and liabilities are offset</span></ix:continuation><span class="fn2"></span><ix:continuation id="C_YL_2" continuedAt="C_YL_3"><span class="fn2">, with</span></ix:continuation><span class="fn2"></span><ix:continuation id="C_YL_3" continuedAt="C_YL_4"><span class="fn2"> the net amounts presented in the financial statements</span></ix:continuation><span class="fn2"></span><ix:continuation id="C_YL_4" continuedAt="C_YL_5"><span class="fn2">,</span></ix:continuation><span class="fn2"></span><ix:continuation id="C_YL_5"><span class="fn2"> when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.</span></ix:continuation></p></div><div class="clbi fn2" style="top:266.2pt;left:67.73pt;width:402.65pt;">Basic financial assets</div><div class="cln" style="top:278pt;left:68pt;width:400pt;text-align:justify;font-family:Calibri;font-size:8.4pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><span class="fn2">Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest</span><span class="fn2"> </span><span class="fn2">method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest.</span><span class="fn2"> Financial assets classified as receivable within one year are not amortised.</span></p></div><div class="clbi fn2" style="top:347.28pt;left:67.73pt;width:402.65pt;">Classification of financial liabilities</div><div class="cln" style="top:359pt;left:68pt;width:400pt;text-align:justify;font-family:Calibri;font-size:8.4pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><span class="fn2">Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.</span></p></div><div class="clbi fn2" style="top:406.23pt;left:67.73pt;width:402.65pt;">Basic financial liabilities</div><div class="cln" style="top:418pt;left:68pt;width:400pt;text-align:justify;font-family:Calibri;font-size:8.4pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><span class="fn2">Basic financial liabilities, including creditors, bank loans, loans from</span><span class="fn2"> </span><span class="fn2">fellow group companies and preference shares that are classified as debt, are</span><span class="fn2"> </span><span class="fn2">initially recognised at transaction price unless the arrangement constitutes a</span><span class="fn2"> </span><span class="fn2">financing transaction, where the debt instrument is measured at the present value of</span><span class="fn2"> </span><span class="fn2">the future </span><span class="fn2">paymen</span><span class="fn2">ts discounted at a market rate of interest.</span><span class="fn2"> Financial liabilities classified as payable within one year are not amortised.</span></p><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><span class="fn2">&#160;</span></p><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><span class="fn2">Debt instruments are subsequently carried at amortised cost, using the effective</span><span class="fn2"> </span><span class="fn2">interest rate method.</span></p><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><span class="fn2">&#160;</span></p><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><span class="fn2">Trade creditors</span><span class="fn2"> are obligations to pay for goods or services that have been acquired</span><span class="fn2"> </span><span class="fn2">in the ordinary course of business from suppliers. A</span><span class="fn2">m</span><span class="fn2">ounts payable are classified as</span><span class="fn2"> </span><span class="fn2">current liabilities if payment is due within one year or less. If not, they are presented</span><span class="fn2"> </span><span class="fn2">as non-current liabilities. Trade creditors are recognised initially at transaction price</span><span class="fn2"> </span><span class="fn2">and subsequently measured at amortised cost using the effective interest method.</span></p></div><div class="clb fn2" style="top:564.84pt;left:46.61pt;width:24.12pt;">1.5</div><div class="clb fn2" style="top:564.84pt;left:67.73pt;width:402.65pt;">Equity instruments</div><div class="cln" style="top:577pt;left:68pt;width:400pt;text-align:justify;font-family:Calibri;font-size:8.4pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><span class="fn2">Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.</span></p></div><div class="clb fn2" style="top:623.96pt;left:46.61pt;width:24.12pt;">1.6</div><div class="clb fn2" style="top:623.96pt;left:67.73pt;width:402.65pt;">Leases</div><div class="cln" style="top:636pt;left:68pt;width:400pt;text-align:justify;font-family:Calibri;font-size:8.4pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><ix:nonNumeric contextRef="C" name="core:LessorOperatingLeasePolicy" continuedAt="C_YM_0"><span class="fn2">Rentals payable under operating leases, </span></ix:nonNumeric><span class="fn2"></span><ix:continuation id="C_YM_0" continuedAt="C_YM_1"><span class="fn2">including</span></ix:continuation><span class="fn2"></span><ix:continuation id="C_YM_1" continuedAt="C_YM_2"><span class="fn2"> any lease incentives received, are charged to </span></ix:continuation><span class="fn2"></span><ix:continuation id="C_YM_2" continuedAt="C_YM_3"><span class="fn2">profit or loss</span></ix:continuation><span class="fn2"></span><ix:continuation id="C_YM_3" continuedAt="C_YM_4"><span class="fn2"> on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the lease</span></ix:continuation><span class="fn2"></span><ix:continuation id="C_YM_4" continuedAt="C_YM_5"><span class="fn2">s</span></ix:continuation><span class="fn2"></span><ix:continuation id="C_YM_5" continuedAt="C_YM_6"><span class="fn2"> asset are consumed.</span></ix:continuation><span class="fn2"> </span></p></div></div><div class="portraitPage" style="height:727pt;width:516pt;"><div class="clb fn2" style="top:31.08pt;left:46.61pt;width:423.77pt;"></div><div class="clb fn2" style="top:42.13pt;left:46.61pt;width:423.77pt;"><ix:nonNumeric contextRef="C" name="bus:EntityCurrentLegalOrRegisteredName">BIO CHI LIMITED</ix:nonNumeric></div><div class="clb fn2" style="top:53.2pt;left:46.61pt;width:423.77pt;"></div><div class="clb fn2" style="top:64.26pt;left:46.61pt;width:423.77pt;">NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)</div><div class="cln fn3" style="top:75.33pt;left:46.61pt;width:420.77pt;"></div><div class="clbi fn2" style="top:81.65pt;left:46.61pt;width:423.77pt;">FOR THE YEAR ENDED 30 JUNE 2019</div><div class="clb fn2" style="top:92.71pt;left:46.61pt;width:423.77pt;"></div><div class="cln fn0 sln" style="top:103.78pt;left:46.61pt;width:420.77pt;"></div><div class="clb fn2" style="top:116.72pt;left:46.61pt;width:24.12pt;">1</div><div class="clb fn2" style="top:116.72pt;left:67.73pt;width:402.65pt;">Accounting policies</div><div class="crb fn2" style="top:116.72pt;left:378.06pt;width:89.32pt;">(Continued)</div><div class="cln fn0 sln" style="top:695.49pt;left:46.61pt;width:420.77pt;"></div><div class="ccn fn1" style="top:701.96pt;left:46.61pt;width:420.77pt;">- 5 -</div><div class="cln" style="top:141pt;left:68pt;width:400pt;text-align:justify;font-family:Calibri;font-size:8.4pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Justify;"><ix:continuation id="C_YM_6"><span class="fn2">Rental income from operating leases is recognised on a straight line basis over the term of the relevant lease. Initial direct costs incurred in negotiating and arranging an operating lease are added to the carrying amount of the leased asset and recognised on a straight line basis over the lease term.</span></ix:continuation></p></div><div class="clb fn2" style="top:187.51pt;left:46.61pt;width:24.12pt;">2</div><div class="clb fn2" style="top:187.51pt;left:67.73pt;width:287.66pt;">Creditors: amounts falling due within one year</div><div class="crb fn2" style="top:199.9pt;left:349.39pt;width:59.56pt;">2019</div><div class="crb fn2" style="top:199.9pt;left:405.95pt;width:61.43pt;">2018</div><div class="crb fn2" style="top:212.29pt;left:349.39pt;width:59.56pt;">£</div><div class="crb fn2" style="top:212.29pt;left:405.95pt;width:61.43pt;">£</div><div class="cln fn4" style="top:212.29pt;left:468.03pt;width:0.65pt;"></div><div class="cln fn2" style="top:237.06pt;left:67.73pt;width:228.1pt;">Bank loans and overdrafts</div><div class="crn fn2" style="top:237.06pt;left:352.39pt;width:56.56pt;"><ix:nonFraction contextRef="B_WQ_XR" decimals="0" scale="0" unitRef="GBP" name="core:BankBorrowingsOverdrafts">349</ix:nonFraction></div><div class="crn fn2" style="top:237.06pt;left:408.95pt;width:58.43pt;">-</div><div class="cln fn2" style="top:249.45pt;left:67.73pt;width:228.1pt;">Other creditors</div><div class="crn fn2" style="top:249.45pt;left:352.39pt;width:56.56pt;"><ix:nonFraction contextRef="B_WQ_XR" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:OtherCreditors">11,325</ix:nonFraction></div><div class="crn fn2" style="top:249.45pt;left:408.95pt;width:58.43pt;"><ix:nonFraction contextRef="E_WQ_XR" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:OtherCreditors">5,800</ix:nonFraction></div><div class="cln fn0 sln" style="top:267.37pt;left:383.72pt;width:25.24pt;"></div><div class="cln fn0 sln" style="top:267.37pt;left:442.15pt;width:25.24pt;"></div><div class="crn fn2" style="top:274.22pt;left:352.39pt;width:56.56pt;"><ix:nonFraction contextRef="B_WQ_XR" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:Creditors">11,674</ix:nonFraction></div><div class="crn fn2" style="top:274.22pt;left:408.95pt;width:58.43pt;"><ix:nonFraction contextRef="E_WQ_XR" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:Creditors">5,800</ix:nonFraction></div><div class="cln fn0 dln" style="top:292.15pt;left:383.72pt;width:25.24pt;"></div><div class="cln fn0 dln" style="top:292.15pt;left:442.15pt;width:25.24pt;"></div></div><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="B" name="bus:EndDateForPeriodCoveredByReport">2019-06-30</ix:nonNumeric><ix:nonNumeric contextRef="B" name="bus:StartDateForPeriodCoveredByReport">2018-07-01</ix:nonNumeric><ix:nonNumeric contextRef="C" name="bus:EntityDormantTruefalse">false</ix:nonNumeric><ix:nonNumeric contextRef="C" name="bus:EntityTradingStatus"></ix:nonNumeric><ix:nonNumeric contextRef="B" format="ixt:datelonguk" name="aurep:DateAuditorsReport">31 March 2020</ix:nonNumeric><ix:nonNumeric contextRef="C_XX_XY" name="bus:LegalFormEntity"></ix:nonNumeric><ix:nonNumeric contextRef="C" name="bus:NameProductionSoftware">CCH Software</ix:nonNumeric><ix:nonNumeric contextRef="C_XZ_YA" name="bus:ApplicableLegislation"></ix:nonNumeric><ix:nonNumeric contextRef="C" name="bus:VersionProductionSoftware">CCH Accounts Production 2019.301</ix:nonNumeric><ix:nonNumeric contextRef="C_YB_YC" name="bus:AccountingStandardsApplied"></ix:nonNumeric><ix:nonNumeric contextRef="C_YD_YE" name="bus:AccountsStatusAuditedOrUnaudited"></ix:nonNumeric><ix:nonNumeric contextRef="C" name="bus:DescriptionPrincipalActivities">No description of principal activity</ix:nonNumeric><ix:nonNumeric contextRef="C" name="bus:ScopeAccounts"></ix:nonNumeric><ix:nonNumeric contextRef="C_WC_WD" name="bus:NameEntityOfficer">Mr T West</ix:nonNumeric><ix:nonNumeric contextRef="C_YG_YH" name="bus:AccountsTypeFullOrAbbreviated"></ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="https://xbrl.frc.org.uk/FRS-102/2019-01-01/FRS-102-2019-01-01.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="C"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">10216240</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_WC_WD"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">10216240</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bus:EntityOfficersDimension">bus:Director1</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_WF_WG"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">10216240</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bus:EntityContactTypeDimension">bus:RegisteredOffice</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="B"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">10216240</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="E"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">10216240</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2018-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="B_WQ_XR"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">10216240</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="core:FinancialInstrumentCurrentNon-currentDimension">core:CurrentFinancialInstruments</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="E_WQ_XR"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">10216240</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="core:FinancialInstrumentCurrentNon-currentDimension">core:CurrentFinancialInstruments</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="B_XT_XU"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">10216240</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="core:EquityClassesDimension">core:RetainedEarningsAccumulatedLosses</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="E_XT_XU"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">10216240</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="core:EquityClassesDimension">core:RetainedEarningsAccumulatedLosses</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_XX_XY"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">10216240</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bus:LegalFormEntityDimension">bus:PrivateLimitedCompanyLtd</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_XZ_YA"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">10216240</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bus:ApplicableLegislationDimension">bus:SmallCompaniesRegimeForAccounts</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_YB_YC"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">10216240</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bus:AccountingStandardsDimension">bus:FRS102</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_YD_YE"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">10216240</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bus:AccountsStatusDimension">bus:AuditExemptWithAccountantsReport</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_YG_YH"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">10216240</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bus:AccountsTypeDimension">bus:FullAccounts</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="Pure"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:unit id="Shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:unit id="GBP"><xbrli:measure>iso4217:GBP</xbrli:measure></xbrli:unit></ix:resources></ix:header></div></body></html>